Hepatitis C Virus Medicines

Product Details:

Velpanat (Sofosbuvir/Velpatasvir  400mg,100mg) Tablet is a combination of two antiviral medicines. This prescription medicine is used in the treatment of chronic hepatitis C virus (HCV) infection. It fights against the viruses to resolve the infection. Velpanat Tablet should be taken in the prescribed dose and duration. It can be taken with or without food, but take it at the same time daily. It is advised not to consume more than the recommended dose. It is important to inform your doctor if you have any health conditions such as liver or kidney disease. It is harmful to consume alcohol along with this medicine, so it is advised to limit or avoid alcohol. The course of the medicine should be completed for better results. The common side effects of this medicine are tiredness and headache. You should drink plenty of fluid and eat a healthy diet to prevent or overcome the side effects. Before taking the medicine, inform your doctor if you are taking any other medicines or supplements. 

Uses Of Velpanat Tablet: 
Treatment of Chronic hepatitis C virus (HCV) infection. 

Benefits Of Velpanat Tablet: 
In Treatment of Chronic hepatitis C virus (HCV) infection Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). When the infection moves into a long-lasting stage, it is called chronic hepatitis C virus infection. Velpanat Tablet helps reduce the number of hepatitis C virus by preventing it from spreading in your body. This helps control the infection and helps you recover faster. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor. 

Side Effects Of Velpanat Tablet: 
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Velpanat Headache Tiredness. 

How To Use Velpanat Tablet: 
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Velpanat Tablet may be taken with or without food, but it is better to take it at a fixed time. 

How Velpanat Tablet Works:
Velpanat Tablet is a combination of two antiviral medicines: Sofosbuvir and Velpatasvir.

Safety Advice: 

• It is not known whether it is safe to consume alcohol with Velpanat Tablet. Please consult your doctor. 
• Velpanat Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies. warnings 
• Velpanat Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. 
• Velpanat Tablet may cause side effects which could affect your ability to drive. Velpanat Tablet, when taken together with other medicines for the treatment of hepatitis c infection, may produce dizziness, blurred vision and this may affect your ability to drive. 
• Velpanat Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Velpanat Tablet may be needed. Please consult your doctor. Limited information is available on the use of Velpanat Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease. 
• Velpanat Tablet is safe to use in patients with liver disease. No dose adjustment of Velpanat Tablet is recommended. However, inform your doctor if you have any kidney disease as regular monitoring of liver function tests may be advised in some patients while taking this medicine.

Product Details:

EPCLUSA (Sofosbuvir/Velpatasvir 400mg,100mg) is a prescription medicine used to treat adults with chronic hepatitis C (Hep C) genotype 1-6 infection with or without cirrhosis.

Product Details:

HARVONI (Ledipasvir/Sofosbuvir 90mg,400mg) is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype (GT) 1, 4, 5 or 6 infection with or without cirrhosis (compensated). In those with GT 1 and advanced cirrhosis (decompensated) or with GT 1 or 4 with or without cirrhosis (compensated) who have had a liver transplant, HARVONI is used with ribavirin. Important Safety Information What is the most important information I should know about HARVONI? HARVONI can cause serious side effects, including: Hepatitis B virus reactivation: Before starting HARVONI treatment, your healthcare provider will do blood tests to check for hepatitis B infection. If you have ever had hepatitis B, the hepatitis B virus could become active again during and after treatment with HARVONI. This may cause serious liver problems, including liver failure and death. If you are at risk, your healthcare provider will monitor you during and after taking HARVONI Tell your healthcare provider about all of your medical conditions, including if you have ever had hepatitis B infection, liver problems other than hepatitis C infection, or a liver transplant; if you have kidney problems or are on dialysis; if you have HIV; or if you are pregnant or breastfeeding or plan to become pregnant or breastfeed. It is not known if HARVONI will harm your unborn baby or pass into your breast milk. If you take HARVONI with ribavirin, you should also read the ribavirin Medication Guide for important pregnancy-related information. HARVONI, when taken with amiodarone (Cordarone®, Nexterone®, Pacerone®), a medicine used to treat certain heart problems, may cause slow heart rate, which in some cases has led to death or the need for a pacemaker. Get medical help right away if you take amiodarone with HARVONI and get any of the following symptoms: fainting or near-fainting, dizziness or lightheadedness, not feeling well, weakness, extreme tiredness, shortness of breath, chest pains, confusion, or memory problems. The most common side effects of HARVONI include tiredness, headache and weakness.

Product Details:

• Sofosbuvir 400 mg Velpatasvir 100 mg Tablets is the global oral tablet for pan-genotypic Chronic Hepatitis C treatment. This combination (Sofosbuvir 400 mg + Valpatasvir 100 mg) drug has been approved by US FDA European Commission for treatment of patients with all genotypic Chronic Hepatitis C virus infection. VELPANAT is used without cirrhosis or with compensated cirrhosis, and patients with advanced cirrhosis (Decompensated). In those with advanced cirrhosis (decompensated), VELPANAT is used with ribavirin.

Therapeutic indications

• Velpanat is indicated for the treatment of adult patients with chronic Hepatitis C Virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infections
• With or without cirrhosis or with compensated cirrhosis
• With decompensated cirrhosis for use in combination with Ribavirin

 

Product Details:

Sofosbuvir/Velpatasvir 400mg,100mg Tablet is a combination of two antiviral medicines. This prescription medicine is used in the treatment of chronic hepatitis C virus (HCV) infection. It fights against the viruses to resolve the infection.
Sofosbuvir/Velpatasvir  Tablet should be taken in the prescribed dose and duration. It can be taken with or without food, but take it at the same time daily. It is advised not to consume more than the recommended dose. It is important to inform your doctor if you have any health conditions such as liver or kidney disease. It is harmful to consume alcohol along with this medicine, so it is advised to limit or avoid alcohol. The course of the medicine should be completed for better results. The common side effects of this medicine are tiredness and headache. You should drink plenty of fluid and eat a healthy diet to prevent or overcome the side effects. Before taking the medicine, inform your doctor if you are taking any other medicines or supplements.

Uses:
Sofosbuvir/Velpatasvir Tablet Treatment of Chronic hepatitis C virus (HCV) infection.

Benefits:
Sofosbuvir/Velpatasvir Tablet Treatment of Chronic hepatitis C virus (HCV) infection Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). When the infection moves into a long-lasting stage, it is called chronic hepatitis C virus infection. Sofosbuvir/Velpatasvir Tablet helps reduce the number of hepatitis C virus by preventing it from spreading in your body. This helps control the infection and helps you recover faster. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor.

Side Effects: 
Sofosbuvir/Velpatasvir Tablet most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Sofosbuvir/Velpatasvir Headache Tiredness.

How To Use: 
Sofosbuvir/Velpatasvir Tablet take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Sofosbuvir/Velpatasvir  Tablet may be taken with or without food, but it is better to take it at a fixed time.
Sofosbuvir/Velpatasvir Tablet Works Sofosbuvir/Velpatasvir  Tablet is a combination of two antiviral medicines: Sofosbuvir and Velpatasvir. They work by lowering the amount of hepatitis C virus in the body and removing the virus from the blood over a period of time. Safety Advice warnings Alcohol Consult Your Doctor It is not known whether it is safe to consume alcohol with Sofosbuvir/Velpatasvir  Tablet. Please consult your doctor. 

Warnings:
Sofosbuvir/Velpatasvir Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies. Sofosbuvir/Velpatasvir  Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. Sofosbuvir/Velpatasvir  Tablet may cause side effects which could affect your ability to drive. Sofosbuvir/Velpatasvir  Tablet, when taken together with other medicines for the treatment of hepatitis c infection, may produce dizziness, blurred vision and this may affect your ability to drive. Sofosbuvir/Velpatasvir Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Sofosbuvir/Velpatasvir Tablet may be needed. Please consult your doctor. Limited information is available o the use of Sofosbuvir/Velpatasvir Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.

Additional Information:

• Production Capacity: NA
• Delivery Time: Immediate
• Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO¿¿¿s TRIPS agreement to which India is a Signatory. On this page we have made an ¿¿¿Honest Reference¿¿¿ of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.

Product Details:

MAVYRET (Glecaprevir & Pibrentasvir 100 Mg/40 Mg) is a prescription medicine used to treat adults and children 12 years of age and older or weighing at least 99 pounds (45 kilograms) with chronic (lasting a long time) hepatitis C virus (hep C): Genotypes (GT) 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis Or GT 1 infection and have been previously treated with a regimen that contained a hep C NS5A inhibitor or an NS3/4A protease inhibitor, but not both. 

Important Safety Information About MAVYRET® (glecaprevir/pibrentasvir) What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver problems, including liver failure and death. Your doctor will monitor you if you are at risk for hep B reactivation during treatment and after you stop taking MAVYRET. Do not take MAVYRET if you: Have certain liver problems Are taking the medicines atazanavir or rifampin What should I tell my doctor before taking MAVYRET? If you have had hep B infection, have liver problems other than hep C infection, have HIV-1 infection, have had a liver or a kidney transplant, and all other medical conditions. If you are pregnantor plan to become pregnant, or if you are breastfeeding or plan to breastfeed. It is not known if MAVYRET will harm your unborn baby or pass into your breast milk. Talk to your doctor about the best way to feed your baby if you take MAVYRET. About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. MAVYRET and other medicines may affect each other. This can cause you to have too much or not enough MAVYRET or other medicines in your body. This may affect the way MAVYRET or your other medicines work or may cause side effects. Do not start taking a new medicine without telling your doctor. Your doctor can tell you if it is safe to take MAVYRET with other medicines. What are the possible side effects of MAVYRET? In people who had or have advanced liver problems before starting treatment with MAVYRET, there is a rare risk of worsening liver problems, liver failure, and death. Your doctor will check you for signs and symptoms of worsening liver problems during treatment with MAVYRET. Tell your doctor right away if you have any of the following: nausea; tiredness; yellowing of your skin or white part of your eyes; bleeding or bruising more easily than normal; confusion; dark, black, or bloody stool; loss of appetite; diarrhea; dark or brown (tea-colored) urine; swelling or pain on the upper right side of your stomach area (abdomen); sleepiness; vomiting of blood; or lightheadedness. The most common side effects of MAVYRET are headache and tiredness. These are not all the possible side effects of MAVYRET. Call your doctor for medical advice about side effects.

Additional Information:

• Production Capacity: NA
• Delivery Time: Immediate
• Packaging Details: "Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO¿¿¿s TRIPS agreement to which India is a Signatory. On this page we have made an ¿¿¿Honest Reference¿¿¿ of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.

Product Details:

Myhep Lvir (Ledipasvir/Sofosbuvir 90mg,400mg) Tablet is a combination of two antiviral medicines. This prescription medicine is used in the treatment of chronic hepatitis C virus (HCV) infection. It fights against the viruses to resolve the infection. Myhep Lvir Tablet should be taken in the prescribed dose and duration. It can be taken with or without food, but take it at the same time daily. It is advised not to consume more than the recommended dose. It is important to inform your doctor if you have any health conditions such as liver or kidney disease. It is harmful to consume alcohol along with this medicine, so it is advised to limit or avoid alcohol. The course of the medicine should be completed for better results. The common side effects of this medicine are tiredness and headache. You should drink plenty of fluid and eat a healthy diet to prevent or overcome the side effects. Before taking the medicine, inform your doctor if you are taking any other medicines or supplements.

Uses Of Myhep LVIR Tablet: 
Treatment of Chronic hepatitis C virus (HCV) infection. 

Benefits Of Myhep LVIR Tablet:
In Treatment of Chronic hepatitis C virus (HCV) infection Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). When the infection moves into a long-lasting stage, it is called chronic hepatitis C virus infection. Myhep Lvir Tablet helps reduce the number of hepatitis C virus by preventing it from spreading in your body. This helps control the infection and helps you recover faster. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor. 

Side Effects Of Myhep LVIR Tablet: 
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Myhep Lvir Tiredness Headache.

How To Use Myhep LVIR Tablet: 
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Myhep Lvir Tablet may be taken with or without food, but it is better to take it at a fixed time. 

How Myhep LVIR Tablet Works: 
Myhep Lvir Tablet is a combination of two antiviral medicines: Ledipasvir and Sofosbuvir. They work by lowering the amount of hepatitis C virus in the body and removing the virus from the blood over a period of time. 

Safety Advice: 

• It is not known whether it is safe to consume alcohol with Myhep Lvir Tablet. Please consult your doctor. 
• Myhep Lvir Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies. 
• Myhep Lvir Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. 
• Myhep Lvir Tablet may cause side effects which could affect your ability to drive. Myhep Lvir Tablet, when taken together with other medicines for the treatment of hepatitis c infection, may produce dizziness, blurred vision and this may affect your ability to drive. 
• Myhep Lvir Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Myhep Lvir Tablet may be needed. Please consult your doctor. Limited information is available on use of Myhep Lvir Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease. 
• Myhep Lvir Tablet is safe to use in patients with liver disease. No dose adjustment of Myhep Lvir Tablet is recommended.

Additional Information:

• Production Capacity: NA
• Delivery Time: Immediate
• Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO¿¿¿s TRIPS agreement to which India is a Signatory. On this page we have made an ¿¿¿Honest Reference¿¿¿ of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.